Professor Anna Mapp, University of Michigan. TBA. Dr. David Sandham, Novartis. "Discovery of novel DP2 receptor antagonists for treatment of asthma: Case history of Fevipiprant."
Dr. Gisele Nishiguchi, Novartis, Inc. " Discovery of the clinical candidate PIM447 for the treatment of cancer - A medicinal chemistry story." Professor Nathanael Gray, Dana Farber Cancer Institute. "Developing New Strategies for Selective Targeting of CDKs to Treat Cancer." Novartis Symposium.
Professor Herbert Waldmann, MPI-Dortmund. Biology Oriented Synthesis. Dr. Chris Brain, Novartis Institute for Biomedical Research. The discovery of LEE011, a selective inhibitor of CDK4/6 for the treatment of cancer.
Location: Pfizer Lecture Hall, 12 Oxford St., Cambridge, 02138 (map) Professor Elizabeth Jarvo, University of California, Irvine. "Mechanism-Based Design and Development of Nickel-Catalyzed Reactions Stereospecific Cross-Coupling Reactions"
